Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
2(66.7%)
N/A
1(33.3%)
3Total
Phase 2(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06306742Phase 2Completed

Open-label Placebo in Manual Therapy

Role: lead

NCT06317675Phase 2Recruiting

Osteopathic Manipulative Treatment for Gastro-oesophageal Reflux Disease

Role: lead

NCT04125498Not ApplicableSuspended

The S-CARE Trial: Manual Treatment for C-sections Scars, a Pilot Study.

Role: lead

NCT05295316Completed

Risk Factors of Primary Fibromyalgia

Role: lead

All 4 trials loaded